Dosage forms of 5-({2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)- propionyl-1-(4-phenyl-1h-imidazol-2-yl)-ethyl-amino}-methyl)-2-methoxy-benzoic acid

摘要

The present invention is directed to novel opioid receptor modulators of Formula: (I). The invention further relates to methods for preparing such compounds, pharmaceutical compositions containing them, and their use in the treatment of disorders that may be ameliorated or treated by the modulation of opioid receptors.